Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 801–900 of 1,004
Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
Huang, Y., Hong, X., Shen, J. X., Geng, L.-J., Pan, Y.-H., Ling, W., & Zhao, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02980 · Cited by 16
“While the proinflammatory cytokines derived from activated cells initially account for the phagocytosis of Aβ, the self-sustaining proinflammatory mediators elicit inducible isoform of nitric oxide (NO) synthase and local NO production to induce neuronal apoptosis, axonal and synaptic damage, and inhibition of mitocho…”
BackgroundPreclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation.
Narayanaswami, V., Tong, J.-C., Schifani, C., Bloomfield, P., Dahl, K., & Vasdev, N. (2021) · PET Clinics · doi:10.1016/j.cpet.2020.12.003 · Cited by 15
Xiao, H., Song, B., Li, Q., Shao, Y., Zhang, Y.-B., Chang, X., & Zhou, Z. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.11.017 · Cited by 18
Bi, A., Wang, Y., Chen, L., Yin, Z., & Luo, L. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110019 · Cited by 17
A rare case of SPG11 mutation with multiple sclerosis
Laurencin, C., Rascle, L., Cotton, F., Grosset-Janin, C., Bernard, E., Depienne, C., Vukusic, S., & Thobois, S. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.03.006 · Cited by 16
“Indeed, studies have shown that neurodegeneration is associated with the presence of several immunological cell types, including cytokines, in the central nervous system [11].”
BackgroundPreoperative Chemerin Level Is Predictive of Inflammatory Status 1 Year After Bariatric Surgery
Jouan, Y., Blasco, H., Bongrani, A., Couet, C., Dupont, J., & Maillot, F. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04584-3 · Cited by 17
Huang, A. Y., Zhou, Z., Talukdar, M., Miller, M. B., Chhouk, B., Enyenihi, L., Rosen, I., Stronge, E., Zhao, B., Kim, D., et al. (2024) · doi:10.1101/2024.01.03.574078 · Cited by 16
Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities
Torres, A. K., Mira, R. G., Pinto, C., & Inestrosa, N. C. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1559151 · Cited by 19
“Additionally, the expression of mutated ALS-associated proteins has been found to activate an innate immune response, leading to an increase in the expression of antimicrobial NLP-29, and the activation of TIR-1/Sarm1 immune pathway (Beers and Appel, 2019; Heneka et al., 2014; Veriepe et al., 2015).”
Intracellular and Mitochondrial Reactive Oxygen Species Measurement in Primary Cultured Neurons
Baek, S. H., Cho, Y., Lee, J., Choi, B. Y., Choi, Y., Park, J. S., Kim, H., Sul, J., Kim, E., Park, J. H., et al. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2871 · Cited by 18
Meyer, P., Savard, M., Poirier, J., Morgan, D., Breitner, J. C. S., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.05.007 · Cited by 16
“These findings led to widespread speculation that AD pathology induced immune activation, which in turn generated a neurotoxic environment, neuronal death, and eventually dementia [69].”
BackgroundFrank, C. J., & McNay, E. C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13074 · Cited by 17
Guha, A., Husain, M. A., Si, Y., Nabors, B., Filippova, N., Promer, G., Smith, R., & King, P. H. (2022) · Glia · doi:10.1002/glia.24288 · Cited by 17
“…their activation and subsequent release of effector molecules such as cytokines, chemokines, matrix metalloproteinases (MMPs), nitric oxide (NO), Prostaglandin E2 (PGE2) (Figure 1) (Acioglu et al., 2021; Dong & Benveniste, 2001; Hamby & Sofroniew, 2010; Heneka et al., 2014; Leng & Edison, 2021).”
BackgroundLiang, S.-Q., Li, P.-H., Hu, Y., Zhao, J., Shao, F.-Z., Kuang, F., Ren, K., Wei, T., Fan, F., Feng, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193081 · Cited by 17
Regulation of Pain Perception by Microbiota in Parkinson Disease
Manjarres, Z., Calvo, M., & Pacheco, R. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000674 · Cited by 15
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 20
Morales-Garcia, J. A., Giné, E., Hernández-Encinas, E., Morante, D. A., Sierra‐Magro, A., Sanz-SanCristóbal, M., Alonso‐Gil, S., Sánchez‐Lanzas, R., Castaño, J. G., Santos, Á., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13269-4 · Cited by 18
Buchert, R., Dirks, M., Schütze, C., Wilke, F., Mamach, M., Wirries, A., Pflugrad, H., Hamann, L., Langer, L., Wetzel, C. H., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04810-1 · Cited by 19
Anti-inflammatory activity of Jatropha curcas L. in brain glial cells primary cultures
Bastos, E. M. S., da Silva, A. B., Coelho, P. L. C., Borges, J. M. P., da Silva, V. D. A., Moreau, V. H., & Costa, S. L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113201 · Cited by 19
Stothert, A. R., & Kaur, T. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.694292 · Cited by 17
Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer’s Disease
Brod, S. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215125 · Cited by 18
“Innate immune cells detect changes in the environment via damage-associated molecular patterns [46], composed of A (cid:2) plaques and other abnormal proteins [47].”
González‐Fernández, C., González, P., González-Pérez, F., & Rodríguez, F. J. (2022) · Brain Sciences · doi:10.3390/brainsci12060708 · Cited by 18
“It is well known that inflammation plays a critical role in the onset and progression of neurodegenerative diseases and traumatic CNS injuries [7,8], including spinal cord injury (SCI) [1,9], which is a devastating neuropathological condition that leads to a severe and irreversible loss of function and permanent disab…”
BackgroundJo, Y. H., Kim, S. B., Liu, Q., Hwang, B. Y., & Lee, M. K. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201600263 · Cited by 16
Yuan, X., Cao, B., Wu, Y., Chen, Y., Wei, Q., Ou, R., Yang, J., Chen, X.-P., Zhao, B., Song, W., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.015 · Cited by 16
Guijarro, I. M., Garcés, M., Andrés‐Benito, P., Marín, B., Otero, A., Barrio, T., Carmona, M., Ferrer, I., Badiola, J. J., & Monzón, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093231 · Cited by 15
Lu, R., Zhou, X., Zhang, L., 张明阳, & Yang, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s478683 · Cited by 15
“7 The nuclear factor-erythroid 2-related-2 (Nrf2) is a pleiotropic transcription factor at the center of a complex regulatory network that modulates cellular defenses against toxic and oxidative damage by expressing genes involved in oxidative stress responses and drug detoxification.”
BackgroundAli, S. A., & Datusalia, A. K. (2025) · Phytotherapy Research · doi:10.1002/ptr.8430 · Cited by 16
“Interestingly, PRRs expressed on innate immune cells lead to activation of the NF-kB and MAPK pathways (Heneka, Kummer, and Latz 2014).”
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration
Sumra, V., Hadian, M., Dilliott, A. A., Farhan, S. M. K., Frank, A. R., Lang, A. E., Roberts, A., Troyer, A. K., Arnott, S. R., Marras, C., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13201-1 · Cited by 18
“CNS innate immune cells (astroglia and microglia) can become activated in response to multiple cellular signals for damage or degeneration, including the recognition of misfolded neuronal proteins and mislocalized nucleic acids from atrophic neurons [10].”
InfluentialExploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management
Singh, B., Mahajan, S., Abdella, S., Khan, R., & Garg, S. (2025) · Medicinal Research Reviews · doi:10.1002/med.70013 · Cited by 18
Arik, E., Heinisch, O., Bienert, M., Gubeljak, L., Slowik, A., Reich, A., Schulz, J. B., Wilhelm, T., Huber, M., & Habib, P. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.915348 · Cited by 17
Kongtawelert, P., Kaewmool, C., Phitak, T., Phimphilai, M., Pothacharoen, P., & Shwe, T. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-15411-3 · Cited by 17
Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease
Alshamrani, M. (2023) · Antibodies · doi:10.3390/antib12020041 · Cited by 22
Steinberg, N., Galleguillos, D., Zaidi, A. K., Horkey, M., & Sipione, S. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02963-y · Cited by 16
Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence
Hamad, A. A., Amer, B. E., Hawas, Y., Mabrouk, M. A., & Meshref, M. M. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07259-w · Cited by 16
“Various immunological cell types, such as cytokines, are expressed and actively present in the brain during neurodegeneration [43].”
BackgroundSharma, S., Risen, S. J., Gilberto, V. S., Boland, S. W., Chatterjee, A., Moreno, J. A., & Nagpal, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00024 · Cited by 13
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis
Losa, M., Emmenegger, M., Rossi, P. D., Schürch, P. M., Serdiuk, T., Pengo, N., Capron, D., Bieli, D., Bargenda, N., Rupp, N. J., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00107-0 · Cited by 15
“There is increasing evidence for an important role of innate immunity in the pathogenesis of protein misfolding diseases (PMDs) (Aguzzi, 2022; Anders and Muruve, 2011; Heneka et al, 2015; Heneka et al, 2014; Jang et al, 2019).”
Neuroinflammation, Type 2 Diabetes, and Dementia
Wong, C. H. Y., Wanrooy, B. J., & Bruce, D. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00010-x · Cited by 18
Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline
Wang, L., Liu, M., Gao, J., Smith, A. M., Fujioka, H., Liang, J., Perry, G. L., & Wang, X. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215175 · Cited by 16
“Among tau pathology-associated inflammatory cytokines, interleukin-1 (cid:2) (IL-1 (cid:2) ) is a major player in the brain and has been repeatedly implicated in the progress of AD [36].”
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 15
Paasila, P. J., Davies, D., Sutherland, G. T., & Goldsbury, C. S. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-2845 · Cited by 25
Zhou, L., Wu, Z., Li, Y., Xie, Y., Sun, L., Lin, S., Xiao, L., Wang, H., & Wang, G. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03082-1 · Cited by 13
“NOD-like receptor thermal protein domain associated protein 3 (NLRP3), a pivotal complex converting stress stimuli into in fl ammatory responses, is predominantly expressed in microglia [16].”
Contemporary trends in targeted protein degradation for neurodegenerative diseases
Kumar, G., Thakur, V., Sardana, S., Tiwari, V. K., Sharma, D., & Kumar, A. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118110 · Cited by 15
Park, S., & Han, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126399 · Cited by 15
“Neuroinflammation is a contributing factor exacerbating the pathology of several neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis [1].”
BackgroundChen, S., Han, S., Hu, C.-F., Zhou, R., Gao, Y., Tu, D., Gao, H., Feng, J., Wang, Y., Lu, R., et al. (2022) · Antioxidants · doi:10.3390/antiox11061202 · Cited by 17
“infection or restoring injuries in the brain [3].”
BackgroundImpact of Aβ40 and Aβ42 Fibrils on the Transcriptome of Primary Astrocytes and Microglia
Zhu, X. A., Schrader, J. M., Irizarry, B. A., Smith, S. O., & Nostrand, W. E. V. (2022) · Biomedicines · doi:10.3390/biomedicines10112982 · Cited by 15
Snyder, A., Grant, H. E., Chou, A., Lindbergh, C. A., Kramer, J. H., Miller, B. L., & Elahi, F. M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12956 · Cited by 16
Sale, A., Noale, M., Cintoli, S., Tognoni, G., Braschi, C., Berardi, N., Maggi, S., Maffei, L., Maffei, L., Picano, E., et al. (2023) · Age and Ageing · doi:10.1093/ageing/afad067 · Cited by 16
Mohamed-Mohamed, H., García‐Morales, V., Sanchez-Lara, E., González‐Acedo, A., Pardo-Moreno, T., Tovar-Gálvez, M. I., Melguizo‐Rodríguez, L., & Ramos‐Rodríguez, J. J. (2023) · Neurology International · doi:10.3390/neurolint15040079 · Cited by 16
“Although most cells involved in this process of neuroinflamma-tion are microglia and astrocytes, capillary endothelial cells are also involved, as well as some infiltrating blood cells, which are more frequent when there is tissue damage in the BBB [180,181].”
BackgroundYou, Q., Hu, M., & Qian, H. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202315199 · Cited by 15
LC3 ‐associated phagocytosis and human diseases: Insights from mechanisms to therapeutic potential
Chen, X., Su, Q., Gong, R., Ling, X., Xu, R., Feng, Q., Ke, J., Liu, M., Kahaerjiang, G., Liu, Y., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202402126r · Cited by 16
“100,101 Additionally, LAP has been implicated in the defense against neurotropic viral pathogens, effectively curtailing the propagation of inflammation and subsequent neuronal injury.”
Ataxin-3 Links NOD2 and TLR2 Mediated Innate Immune Sensing and Metabolism in Myeloid Cells
Chapman, T., Corridoni, D., Shiraishi, S., Pandey, S., Aulicino, A., Wigfield, S., Costa, M. D. C., Thézénas, M., Paulson, H. L., Fischer, R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01495 · Cited by 16
“In humans, mutations confer an increased risk for the neurodegenerative diseases Alzheimer’s (51) and spinocerebellar ataxia (52), with increasing evidence of the role of innate immune dysfunction in neurodegeneration (53).”
BackgroundAssociation between ALS and retroviruses: evidence from bioinformatics analysis
Klein, J. P., Sun, Z., & Staff, N. P. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3249-8 · Cited by 15
Sánchez-Cruz, A., Méndez, A. C., Lizasoaín, I., de la Villa, P., de la Rosa, E. J., & Hernández‐Sánchez, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157815 · Cited by 14
“Toll-like receptors (TLRs) are part of the PRR superfamily and in the central nervous system (CNS) are predominantly expressed by microglia [8,10,11].”
BackgroundInfluentialCheng, Y., Chen, B., Bian, G., Ding, Y., & Chen, L.-W. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02758-x · Cited by 13
Keenan, R. J., Chan, J., Donnelly, P. S., Barnham, K. J., & Jacobson, L. H. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.09.008 · Cited by 18
The Role of Long Noncoding RNAs in Diabetic Alzheimer’s Disease
Kim, Y., & Song, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110461 · Cited by 13
Pollock, T. B., Cholico, G. N., Isho, N. F., Day, R. J., Suresh, T., Stewart, E. S., McCarthy, M. M., & Rohn, T. T. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00256 · Cited by 14
“These results suggest a novel role for ApoE and further, potentially link harboring the APOE4 allele to inflammation and degeneration that has long been associated with AD (Streit, 2005; Graeber and Streit, 2010; Heneka et al., 2014; Das and Chinnathambi, 2019).”
BackgroundIslam, M. T., Mubarak, M. S., Hossain, R., Jain, D., Khan, R. A., & Saikat, A. S. M. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210623104227 · Cited by 15
Repeated performance of spatial memory tasks ameliorates cognitive decline in APP/PS1 mice
Lonnemann, N., Körte, M., & Hosseini, S. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114218 · Cited by 12
Wang, T., Wu, B., Zhang, X., Zhang, M., Zhang, S., Huang, W., Liu, T., Yu, W., Li, J., & Yu, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27908 · Cited by 13
“46 The upregulation of Tyrobp had been identified in the injured nerves.”
BackgroundSerum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers
Maeba, R., Araki, A., & Fujiwara, Y. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.08.001 · Cited by 16
The Immune System: Our Body’s Homeland Security Against Disease
Vojdani, A., Vojdani, E., & Vojdani, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-30730-1_19 · Cited by 12
Shermon, S., Goldfinger, M. S., Morris, A. J., Harper, B. D., Leder, A. N., Santella, A. J., & Krishnamachari, B. (2021) · Chronic Illness · doi:10.1177/17423953211039789 · Cited by 14
Immunosenescence of brain accelerates Alzheimer’s disease progression
Chen, H.-Y., Zhao, Y. G., & Xie, Y. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0021 · Cited by 12
Genome integrity and inflammation in the nervous system
Aditi, A., & McKinnon, P. J. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103406 · Cited by 14
Balbi, M., Bonanno, G., Bonifacino, T., & Milanese, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065240 · Cited by 14
“The SOD1G93A mouse model of ALS demonstrated that the disease onset is associated with microglial activation and TNF-α, IL-6, and IL-1β production, suggesting that the SOD1 mutant protein may trigger a pathogenic response in microglia [259].”
BackgroundKarima, S., Aghamollaii, V., Baram, S. M., Balenci, L., Lanctôt, K. L., Kiss, A., Tafakhori, A., Mahdavi, M., Rajaei, S., Shateri, S., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221026 · Cited by 15
“Over the last few years, inflammation has been increasingly recognized as a major player in AD [51, 52].”
Liu, Z., Bai, Y.-D., Yu, Z., Li, H., Liu, J., Tan, C., Zeng, G., Tu, Y., Sun, P., Jia, Y., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01077-y · Cited by 18
PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice
Kordala, A. J., Stoodley, J., Ahlskog, N., Hanifi, M., Garcia-Guerra, A., Bhomra, A., Lim, W. F., Murray, L. M., Talbot, K., Hammond, S. M., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317683 · Cited by 14
“…chronic microglia activation have been observed early in SMA and other neurological conditions (Eikelen-boom et al , 2002; Sargsyan et al , 2005; Heneka et al , 2014; Vukojicic et al , 2019) and play a determinative role in the disease pathogenesis (Mcgivern et al , 2013; Rindt et al , 2015;…”
BackgroundThe major histocompatibility complex participates in Parkinson’s disease
Gu, R., Pan, J., Awan, M. U. N., Sun, X., Fang, Y., Bai, L., & Bai, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107168 · Cited by 15
Liu, D., Hsueh, S., Tweedie, D., Price, N., Glotfelty, E. J., Lecca, D., Telljohann, R. S., de Cabo, R., Hoffer, B. J., & Greig, N. H. (2024) · Brain Communications · doi:10.1093/braincomms/fcae204 · Cited by 14
“53 Excessive and prolonged microglia activation, as well as other components of the innate and adaptive immune response, could drive chronic inflammation and be detrimental to the micro-environment and neighbouring cells, which, in turn, contribute to BF atrophy in individuals at risk of AD, as has…”
BackgroundFeng, X., Luo, Y., Zheng, M., Sun, X., & Shen, X. (2024) · Environment & Health · doi:10.1021/envhealth.4c00097 · Cited by 13
Ovesen, P. L., Juul‐Madsen, K., Telugu, N. S., Schmidt, V., Frahm, S., Radbruch, H., Louth, E. L., Korshøj, A. R., Heppner, F. L., Diecke, S., et al. (2025) · Glia · doi:10.1002/glia.24659 · Cited by 14
“Neuroinflammation is a hallmark of AD pathology with microglia playing central roles in mediating inflammatory responses in the diseased brain (Heneka, Kummer, and Latz 2014; Heppner, Ransohoff, and Becher 2015).”
Neuroinflammation is not a Prerequisite for Diabetes-induced Tau Phosphorylation
van der Harg, J. M., Eggels, L., Ruigrok, S. R., Hoozemans, J. J. M., la Fleur, S. E., & Scheper, W. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00432 · Cited by 13
“Indeed, neuropathological and experimental studies demonstrate that Aβ can activate the immune system including the pro-inflammatory cytokine cascade (Eikelenboom et al., 2012; Heneka et al., 2014).”
BackgroundPradeu, T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108616706 · Cited by 150
“This is the case, for example, for some neurodegenerative disorders (Heneka et al. 2014) such as multiple sclerosis, which is an autoimmune disease (Dendrou et al. 2015), but also in Alzheimer’s disease (Heppner et al. 2015).”
BackgroundInfluentialNeurofilament degradation is involved in laparotomy-induced cognitive dysfunction in aged rats
Cao, Y., Liu, T., Li, Z., Jiao, Y., Ma, L., Mi, X., Yang, N., Qi, A., Guo, X., & Wang, A. (2020) · Aging · doi:10.18632/aging.104172 · Cited by 14
“Dysfunction of microglia is involved in the amplification of the immune response in the pathophysiology of neurological disorders, including ischemic stroke [8] and neurodegenerative diseases [9, 10].”
BackgroundGu, L., Zhou, Y., Wang, G., Deng, H., Song, X., He, X., Wang, T., Chen, X., Dai, J., & Li, R. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.092 · Cited by 15
Borgenheimer, E., Hamel, K. A., Sheeler, C. A., Labrada-Moncada, F. E., Sbrocco, K., Zhang, Y., & Cvetanović, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.998408 · Cited by 14
“In some situations, reactive gliosis was beneficial by delaying and ameliorating pathogenesis, but reactive glia may also be harmful and can exacerbate neuronal dysfunction and disease pathogenesis (Heneka et al., 2014; Pekny et al., 2014; Kim et al., 2018).”
BackgroundRoadmap on nanomedicine for the central nervous system
Ciofani, G., Campisi, M., Mattu, C., Kamm, R. D., Chiono, V., Raynold, A. A. M., Freitas, J. S., Riva, E. R., Micera, S., Pucci, C., et al. (2022) · Journal of Physics Materials · doi:10.1088/2515-7639/acab88 · Cited by 12
Brain-immune interactions in health and disease
Dénes, Á., & Miyan, J. A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00382 · Cited by 12
“…and hematological diseases further implicating dependent interrelationships between the immune system and the brain (Denes et al., 2010; Moreno-Smith et al., 2010; Deretzi et al., 2011; Iadecola and Anrather, 2011; Wraith and Nicholson, 2012; Theoharides et al., 2013; Heneka et al., 2014).”
BackgroundThe Pivotal Neuroinflammatory, Therapeutic and Neuroprotective Role of Alpha-Mangostin
Richard, S. A., Zheng, S., Su, Z., Gao, J., & Xu, H. (2017) · Journal of Neurology Research · doi:10.14740/jnr455w · Cited by 12
González‐Castro, R., Acero, G., Salcedo, Y. G., Uribe-Campero, L., Perez, V. V., Carrillo‐Tripp, M., Gevorkian, G., & Gómez-Lim, M. Á. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0408-2 · Cited by 15
“On the other hand, it is well documented that the beneficial effect of immunotherapy may be counteracted by the exacerbation of the chronic inflammatory environment in AD brain (Heneka et al. 2014; Pasqualetti et al. 2015).”
The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Conceição, A. R., Marinatto, J., Pinheiro, L. S., Rody, T., & Felice, F. G. D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70209 · Cited by 16
“Neuroinflammation, characterized by immune responses within the CNS, stands as a central player in various neurological disorders, such as AD, multiple sclerosis, Parkinson's disease, and hepatic encephalopathy (Heneka et al. 2014; Cabrera-Pastor et al. 2019).”
Guo, X., Zhang, G., Peng, Q., Liu, H., Ye, K., Xiao, T., Liu, C., Zhang, X., Li, S., Wang, H., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106158 · Cited by 14
Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration
Kwon, H. J., Ahn, J. H., Won, M.-H., & Kim, D. H. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03664-4 · Cited by 14
“In particular, the chronic elevation of circulating pro-inflammatory cytokines—such as interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), IL-6—may disrupt the integrity of the BBB, activate microglial cells, and promote neuronal dysfunction and synaptic loss [10, 11].”
COX-2 inhibitors in inflammation and cancer: Recent developments in medicinal chemistry
Chahat, Gupta, S., Joshi, G., Wahajuddin, M., & Kumar, B. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118781 · Cited by 16
Perampanel for amyotrophic lateral sclerosis: A systematic review and meta-analysis
Turalde, C. W. R., Moalong, K. M. C., Espiritu, A. I., & Prado, M. B. (2022) · Neurological Sciences · doi:10.1007/s10072-022-05867-6 · Cited by 12
“Although recent animal studies demonstrate that perampanel significantly ameliorates TDP-43 pathology in motor neurons [17], this does not take into consideration the other hypothesized patho-mechanisms involved in ALS, such as cytoplasmic accumulation of other proteins such as FUS [28], OPTN [29], C9ORF72 [30], UBQLN…”
BackgroundResultMerlo, S., Caruso, G. I., Korde, D. S., Khodorovska, A. A., Humpel, C., & Sortino, M. A. (2023) · Biomolecules · doi:10.3390/biom13020373 · Cited by 13
“A shared feature among these pathologies is neuroinflammation, a complex process mediated primarily by microglia and astrocytes [29].”
BackgroundEffects of Current Psychotropic Drugs on Inflammation and Immune System
Bhatt, S., Dhar, A. K., Samanta, M. K., & Suttee, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_18 · Cited by 13
Yang, M., Zhu, H., Peng, L., Yin, T., Sun, S., Du, Y., Li, J., Liu, J., & Wang, S. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114906 · Cited by 11
“Microglia are capable of responding to IL-18, which promotes their activation and enhances their phagocytosis, ultimately resulting in the loss of synapses and neurons (Alboni et al., 2010; Heneka et al., 2014; Mori et al., 2001).”
BackgroundHe, J., Wu, T., Shirong, Y., Ma, L., Jing, L., Shihui, M., Haijian, Y., & Yu, F. H. Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112849 · Cited by 15
Shen, J., Ji, X. Z., Han, L., Yao, J., Liang, Y., Yuan, M., Xu, S., & Li, Z. (2024) · mSystems · doi:10.1128/msystems.00893-24 · Cited by 11
“Apoptosis of these cells, driven by bacterial proteins such as NbtS, could lead to dysregulated immune responses and exacerbate neuronal damage (30).”
BackgroundZhang, Q., Zheng, M., Sun, W., Loers, G., Wen, M., Wang, Q., Zheng, X., Siebert, H., Zhang, R., & Zhang, N. (2025) · Food & Function · doi:10.1039/d5fo00422e · Cited by 16
Lye, S., Aust, C. E., Griffiths, L. R., & Fernandez, F. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117332 · Cited by 11
Chen, X., Chen, Y., Qi, D., & Cui, D. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110422 · Cited by 13
Impact of eugenol onin vivomodel of 6-hydroxydopamine-induced oxidative stress
Pontes, N. H. L., dos Reis, T. D. D. S., Vasconcelos, C. F. M., de Aragão, P. D. T. T. D., Souza, R. B., Júnior, F. E. A. C., Aguiar, L. M. V., & da Cunha, R. M. S. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1971662 · Cited by 12
Al‐Onaizi, M., Al-Sarraf, A. J., Braysh, K., Kazem, F., Al‐Hussaini, H., Rao, M. S. R., Kilarkaje, N., & ElAli, A. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15835 · Cited by 13
“Indeed, the pathological hallmarks of AD trigger a sustained central inflammatory response associated with abnormal activity of microglia, which release pro-inflammatory cytokines implicated in worsening AD pathology (Galloway et al., 2019; Heneka et al., 2014; Wyss-Coray, 2006; Zuena et al., 2019).”
BackgroundApoptosis signal-regulating kinase 1 mediates striatal degeneration via the regulation of C1q
Cho, K., Cheon, S. Y., & Kim, G. W. (2016) · Scientific Reports · doi:10.1038/srep18840 · Cited by 11
Qian, L., Zhang, C., Mao, Y., Li, L., Gao, N., Lim, K., Xu, Q., & Yao, S. Q. (2016) · Scientific Reports · doi:10.1038/srep26385 · Cited by 11
“Dysregulation of these enzymes may cause a variety of diseases including neurodegenerative diseases 1–4 .”
InfluentialGao, M., Dong, Q., Yao, H., Lu, Y., Ji, X., Zou, M., Yang, Z., Xu, M., & Xu, R. (2017) · Scientific Reports · doi:10.1038/srep45989 · Cited by 11
Curcumin and Inflammatory Brain Diseases
Shehzad, A., Islam, S. U., & Lee, Y. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00024-4 · Cited by 16
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.